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Hypothermia is a standard treatment for neonatal encephalopathy, but nearly 50% of
treated infants have adverse outcomes. Pharmacological therapies can act through
complementary mechanisms with hypothermia improving neuroprotection. Cannabidiol
could be a good candidate. Our aim was to test whether immediate treatment
with cannabidiol and hypothermia act through complementary brain pathways in
hypoxic-ischemic newborn piglets. Hypoxic-ischemic animals were randomly divided
into four groups receiving 30 min after the insult: (1) normothermia and vehicle
administration; (2) normothermia and cannabidiol administration; (3) hypothermia
and vehicle administration; and (4) hypothermia and cannabidiol administration. Six
hours after treatment, brains were processed to quantify the number of damaged
neurons by Nissl staining. Proton nuclear magnetic resonance spectra were obtained
and analyzed for lactate, N-acetyl-aspartate and glutamate. Metabolite ratios were
calculated to assess neuronal damage (lactate/N-acetyl-aspartate) and excitotoxicity
(glutamate/Nacetyl-aspartate). Western blot studies were performed to quantify
protein nitrosylation (oxidative stress), content of caspase-3 (apoptosis) and TNFα
(inflammation). Individually, the hypothermia and the cannabidiol treatments reduced
the glutamate/Nacetyl-aspartate ratio, as well as TNFα and oxidized protein levels in
newborn piglets subjected to hypoxic-ischemic insult. Also, both therapies reduced the
number of necrotic neurons and prevented an increase in lactate/N-acetyl-aspartate
ratio. The combined effect of hypothermia and cannabidiol on excitotoxicity, inflammation
and oxidative stress, and on cell damage, was greater than either hypothermia or
cannabidiol alone. The present study demonstrated that cannabidiol and hypothermia
act complementarily and show additive effects on the main factors leading to
hypoxic-ischemic brain damage if applied shortly after the insult.
Keywords: hypothermia, neonatal brain, neurodevelopment, neuroprotection, hypoxic-ischemic encephalopathy,
newborn animal, cannabidiol
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INTRODUCTION
Excitotoxicity, inflammation and oxidative stress are the “deadly
triad” leading to hypoxia-ischemia (HI)-induced brain damage
(Johnston et al., 2011; Drury et al., 2014; Juul and Ferriero,
2014). Only pleiotropic therapies acting on all these processes
provide successful neuroprotection (Cilio and Ferriero, 2010;
Johnston et al., 2011; Juul and Ferriero, 2014). Therapeutic
hypothermia is an example of a pleiotropic neuroprotective
therapy (Drury et al., 2014). Studies in immature an adult
animals have demonstrated antiexcitotoxic, anti-oxidant, and
anti-inflammatory effects of hypothermia (Thoresen et al., 1997;
Mueller-Burke et al., 2008; Jenkins et al., 2012; Joseph et al.,
2012; Sandu et al., 2016) which become the gold standard for
treating infants with hypoxic-ischemic encephalopathy (HIE;
Jacobs et al., 2013). Despite treatment with hypothermia, some
infants with neonatal HIE present adverse outcomes. Further
trials to determine the appropriate techniques of cooling,
including refinement of patient selection, duration of cooling
and method of providing therapeutic hypothermia, will improve
our understanding of this therapy (Jacobs et al., 2013). In
addition, a recent meta-analysis reported that hypothermia is
not protective and can even be harmful in low- and middle-
income countries in Africa and Asia (Pauliah et al., 2013).
In this context, complementary therapies can be combined
with hypothermia to enhance its neuroprotective properties
and/or extend its therapeutic time window. These therapies
might even become an alternative to hypothermia when needed
(Cilio and Ferriero, 2010). On the other hand, a successful
treatment for HIE neuroprotection may not be complementary
to hypothermia if its mechanisms of action overlap with those
of hypothermia without any improvement of the outcome. Thus,
IGF-1 (George et al., 2011) or SOD mimetic EUK-134 (Ni et al.,
2012) therapies failed to demonstrate additive neuroprotective
effects when combined with hypothermia. By contrast, other
therapies such as xenon or melatonin (Chakkarapani et al., 2010;
Faulkner et al., 2011; Robertson et al., 2013), have been observed
to augment hypothermic neuroprotection at least in some
situations, showing additive protection with mild hypothermia.
Cannabidiol (CBD), the main non-psychoactive component
of Cannabis sativa, has recently been included among pleiotropic
therapies, as it has been shown to reduce HI-induced brain
damage in newborn rats and piglets by modulating excitotoxicity,
inflammation and oxidative stress (Alvarez et al., 2008; Castillo
et al., 2010; Lafuente et al., 2011; Pazos et al., 2012, 2013).
Some of the properties of CBD underlying these effects include
its antioxidant properties, the inhibition of calcium transport
across membranes, inhibition of endocannabinoid uptake and
enzymatic hydrolysis, activation of serotonin 5HT1A receptors
and inhibition of NF-κB activation (Alvarez et al., 2008; Castillo
et al., 2010; Lafuente et al., 2011; Pazos et al., 2012, 2013).
The neuroprotective action of CBD was not associated with
significant side effects, and additional benefits were demonstrated
if immediate rescue treatment was provided (Alvarez et al., 2008;
Lafuente et al., 2011; Pazos et al., 2012, 2013). In summary,
these studies support the role of CBD as a non-artificial drug
for newborns with HIE. However, no evidences of how CBD
might work together with hypothermia have been provided
so far.
Our aim was to assess the early effects of combining
cannabidiol with therapeutic hypothermia in neonatal hypoxic-
ischemic piglets using clinical biomarkers of brain injury shortly
after the injury.
MATERIALS AND METHODS
All experimental procedures and euthanasia of the animals were
conducted in strict compliance with European and Spanish
regulations on the protection of animals used for scientific
purposes (European Directive 2010/63/EU and Spanish Royal
Legislative Decree 53/2013). The protocols were approved by
the Committees on the Ethics of Laboratory Animal Welfare of
Biocruces Health Research Institute and the Research Institute
Puerta de Hierro Majadahonda (Permit Numbers: SEP#009_09
and SEP#012_11) and performed in its experimental surgical
theaters. Using G∗Power 3.0 (Faul et al., 2007), the change in
the area under the curve for lactate/N-acetyl aspartate from
baseline at 6 h was used as the primary outcome to calculate the
sample size. Our previous work in this model suggested that the
change in lactate/N-acetyl aspartate ratio after 6 h varied between
vehicle-treated and cannabidiol-treated groups by 50 ± 20%.
Assuming similar magnitude of additional effect for cannabidiol-
augmented hypothermia (vs. hypothermia or cannabidiol alone)
and with an alpha risk of 0.05 and a beta risk of 0.2, eight subjects
would be necessary in each group. It was anticipated a drop-
out rate of 5%. All experimental procedures were designed and
carried out by personnel qualified in Laboratory Animal Science,
following FELASA recommendations (Category B and C). All
surgery was performed under adequate anesthesia and analgesia,
and great efforts were made to minimize suffering.
Experimental Protocol
Animals were daily obtained from a local vendor with specific
pathogen free status for international swine breeding program
(TOPIG, B-line) and for in vitro genetic reproduction (Arri-
Turri farm, Alava, Spain). In short, 1- to 2-day-old male
piglets were intubated under 5% sevoflurane anesthesia and
managed by controlled mechanical ventilation (VIP Bird, Bird
Corp., Palm Springs, CA, USA). A marginal ear vein was
cannulated to maintain intravascular anesthesia and analgesia
by continuous infusion of 3 mg/kg/h propofol, 0.5 mg/kg/h
midazolam, and 4 µg/kg/h fentanyl. Once adequate analgesia
was achieved and confirmed, respiratory paralysis was induced
with 3 mg/kg/h atracurium to prevent spontaneous breathing.
Then, the two common carotid arteries were exposed and
elastic bands were placed loosely around each one. A non-
invasive ultrasonic probe (Transonic Systems Inc., NY) was
placed in the right common carotid artery to measure the
instantaneous blood flow. Indwelling catheters (5 Fr, PiCCO
Plus, Pulsion Medical Systems, München, Germany) were
inserted into the right jugular vein, to infuse dextrose (at
a rate of 4 mg/kg/min), and into the right femoral artery
to continuously monitor cardiac output, heart rate, mean
arterial blood pressure and central temperature (Omnicare
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CMS 24, HP, Göblingen, Germany). Further, brain activity
was monitored by amplitude-integrated electroencephalography
(aEEG; BRM2; BrainZ Instruments, Auckland, New Zealand).
The “raw” EEG traces were manually reviewed for electrical
seizures. Body temperature was maintained between 37.5 and
38.5◦C using an air-warmed blanket. Arterial blood gases were
monitored throughout the experiment. Dopamine infusion (10–
20µg/kg/min) was used as needed to maintain mean arterial
blood pressure over 40 mmHg (Chakkarapani et al., 2010;
Faulkner et al., 2011; Robertson et al., 2013). After surgical
instrumentation, each animal was left to stabilize for 30 min
(baseline).
After the surgery, HI brain injury was induced in the piglets
by total interruption of the carotid blood flow (tightening the
elastic bands around the arteries, and confirmed by the ultrasonic
probe) and reducing the fraction of inspired oxygen to less than
10%. The hypoxic-ischemic conditions were maintained for 30
min, measured from the point at which there was evidence of
reduced brain activity on the aEEG (flat traces < 4 µV). After
this period of injury (end of HI), carotid blood flow was restored
and the inspired fraction of oxygen was returned to 21%.
After 30min, control and HI-injured piglets were
first randomized by sealed envelope to normothermia or
hypothermia. In normothermic animals, rectal temperature was
maintained at 38◦C (range: 37.5–38.5◦C) using the air-warmed
blanket. In hypothermic animals, based on previously reported
studies for combination of therapies in hypoxic-ischemic piglets
(Chakkarapani et al., 2010; Faulkner et al., 2011; Robertson
et al., 2013), rectal temperature was reduced within 10 min to
33–34◦C using a circulating water mattress (Recirculating Chiller
1171MD, VWR International, CA, USA).
Then, HI-injured piglets treated with normothermia or
hypothermia were again randomized for drug administration
by sealed envelope. CBD (a generous gift by GW Pharma Ltd,
Mambridge, UK) was prepared in a 5 mg/mL formulation of
ethanol/solutol/saline (2:1:17), as reported in previous studies
(Alvarez et al., 2008; Lafuente et al., 2011; Pazos et al., 2012, 2013).
Doses were selected following previous in vivo experiments by
our group (Pazos et al., 2012, 2013) and HI-injured animals
received i.v. 1mg/kg (0.2mL/kg) of CBD or an equivalent volume
of vehicle (ethanol/solutol/saline), further diluted to 10 mL in
saline before administration as slow bolus.
After 6 h of treatment, anesthetized piglets were euthanized
by cardiac arrest with potassium chloride (∼150 mg/kg), and the
brains were immediately removed from the skull and sliced. Brain
slices were placed into 4% paraformaldehyde, for histological
analysis (left hemisphere), or frozen in isopentane and conserved
at −80◦C, for spectroscopy and biochemical analysis (right
hemisphere). For both types of analysis, we used parietal cortex
samples from the same brain section, corresponding to 5mm of
the posterior brain region identified according to the stereotaxic
atlas of the pig brain (Felix et al., 1999).
Accordingly, there were four experimental groups of HI
piglets: normothermic vehicle-treated group (NV; n = 9),
normothermic cannabidiol-treated group (NC; n = 11),
hypothermic vehicle-treated group (HV; n= 8) and hypothermic
cannabidiol-treated group (HC; n = 8). Normothermic and
hypothermic sham operated groups of animals without HI are
included in supplemental files as referenced data.
Histological Analysis
Neuronal necrosis was identified by Nissl staining in 4-µm
thick coronal sections obtained from fixed brain hemispheres, as
described previously (Alvarez et al., 2008; Lafuente et al., 2011;
Pazos et al., 2013). Random areas were examined in the three
central lobes of the parietal cortex, focusing on 1-mm2 areas in
the layers II-III. This analysis was conducted by a pathologist
investigator blinded to the experimental groups using an optical
microscope at 400x and a grid of 50 compartments, with the
mean of three compartments being calculated. The parietal cortex
was selected to illustrate histological brain damage because this is
the most vulnerable area in the brain to HI in piglets, and because
the damage seen in this area correlates with that observed in other
vulnerable areas such as the hippocampus or striatum (Peeters-
Scholte et al., 2003; Schubert et al., 2005). Normal neuronal
cells were recognized by the presence of the typical nuclei
with clear nucleoplasm and distinct nucleolus surrounded by
purple-stained cytoplasm containing Nissl substance. Neurons
were classified as damaged cells (pyknotic or necrotic) when we
were unable to ascertain a well-defined nuclear and cytoplasmic
boundary.
Proton Magnetic Resonance Spectroscopy
(H+-MRS)
Ex vivo proton magnetic resonance spectroscopy (H+-MRS)
has been demonstrated to provide metabolic information
with higher sensitivity and spectral resolution than in vivo
magnetic resonance spectroscopy (Jiménez-Xarrié et al., 2015).
As previously described (Pazos et al., 2013), H+-MRS was
performed in the MRI Unit of the Instituto Pluridisciplinar
(Universidad Complutense, Madrid, Spain) at 500.13 MHz using
a Bruker AMX500 spectrometer at 11.7 T, operating at 4◦C on
frozen parietal cortical samples (5–10mg weight) placed within a
50-µL zirconium oxide rotor with a cylindrical insert and spun
at a rate of 4000 Hz. H+-MRS spectra were acquired using a
standard solvent-suppressed pulse/acquire sequence based on the
start of a Nuclear Overhauser Effect Spectroscopy pulse sequence,
with 16,000 data points, averaged over 256 acquisitions. Data
acquisition time was approximately 14 min. The NOESY preset
pulse sequence employed a mixing time of 150 ms with t1
fixed at 3 µs, during which time the effects of B0 and B1 field
inhomogeneities were suppressed (relaxation delay-90◦-t1-90◦-
tm-90◦-acquire free induction decay signal). A secondary radio-
frequency field was applied at the water resonance frequency
during the relaxation delay of 2 s.
A spectral width of 8333.33 Hz was used. All spectra
were processed using TOPSPIN software, version 1.3 (Bruker
Rheinstetten, Germany). Prior to Fourier transformation, the
free induction decay values were multiplied by an exponential
weight function corresponding to a line broadening of 0.3 Hz.
Spectra were phased, baseline-corrected and referenced to the
sodium (3-trimethylsilyl)-2,2,3,3-tetradeuteriopropionate singlet
at δ= 0 ppm.
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After curve fitting was performed (SpinWorks ver.
3.1.7.0, University of Manitoba, Canada), all spectra were
analyzed for lactate (Lac), N-acetyl-aspartate (NAA), and
glutamate (Glu). Later, several ratios were calculated
that are predictive of neurodevelopmental outcome after
hypoxic-ischemic brain damage in piglets (Vial et al., 2004;
Munkeby et al., 2008): lactate/N-acetylaspartate (Lac/NAA) and
glutamate/N-acetylaspartate (Glu/NAA).
Western Blot Studies
Levels of oxidized proteins were quantified by Western blot
analysis to assess protein carbonylation in brain tissue. A
detection kit (Millipore Iberica; Madrid, Spain) was used
according to the manufacturer’s protocol, and brain samples
containing 15 µg of total protein were subjected to the
derivatization reaction with 2,4-dinitrophenylhydrazine
(DNPH). Two aliquots of each sample to be analyzed were
treated: one aliquot was subjected to derivatization reaction, and
the other aliquot, served as a negative control, by substituting
the derivatization control solution with DNPH solution. The
treated samples were fractionated in a 12% dodecyl-sulfate–
polyacrylamide gel and electroblotted onto PVDF membranes
(GE Healthcare; Buckinghamshire, UK). DNPH-BSA standards
(Millipore Iberica, Madrid, Spain) were loaded on each
gel and used as a reference. Membranes were incubated in
Tris/glycine/methanol transfer buffer at 4◦C and proteins
separated under constant voltage (2 h at 250 mA). The resulting
blots were blocked by overnight incubation in phosphate-
buffered saline-Tween (PBST) containing 5% nonfat dried
milk at 4◦C. Primary antibody incubation (Rabbit Anti-DNPH
1:150; Millipore Iberica, Madrid, Spain) was performed in PBST
containing 5% nonfat dried milk for 1 h at room temperature.
After washing with PBST, the membranes were incubated with
the secondary antibody (Goat anti-rabbit IgG HRP conjugated
1:300; Millipore Iberica, Madrid, Spain) for 1 h at room
temperature. Finally, an enhanced chemiluminescent substrate
detection system (GE Healthcare, Buckinghamshire, UK) was
used to visualize the blots. The films were scanned and analyzed
with ImageJ software (NIH, USA). Oxidized protein levels were
quantified via measurement of the optical density, using the NIH
Image J analysis software (Bethesda, MD, USA). Results were
normalized by total protein loading (Red Ponceau staining) and
expressed as OxyBlot/Red Ponceau ratio.
TNFα and caspase-3 Western blot assays were performed
with brain samples containing 20 µg of total protein. In
this case, proteins were electrophoresed in an 18% sodium
dodecyl-sulfate–polyacrylamide gel and then electroblotted onto
PVDF membranes (GE Healthcare, Buckinghamshire, UK) in
Tris/glycine/methanol transfer buffer under constant voltage (2 h
at 250 mA). The resulting blots were blocked in PBST containing
5% nonfat dried milk at room temperature for 1 h, followed
by primary antibody incubation (Rabbit anti-TNFα 1:1000, and
rabbit anti-Caspase-3 1:500; Abcam Plc., Cambridge, UK) in
PBST containing 5% nonfat dried milk at 4◦C overnight. After
washing with PBST, the membranes were incubated with the
secondary antibody (Goat anti-rabbit IgG HRP-Conjugated for
TNFα and goat anti-mouse IgG HRP-Conjugated for caspase-
3, 1:2000; Bio-Rad Lab., Hercules, CA, USA) for 1 h at room
temperature. Finally, as above, the ECL system was used, and the
films were scanned and analyzed using ImageJ software. Protein
levels were quantified using densitometric analysis, normalized
by β-actin (1:500, Abcam Plc., Cambridge, UK) loading and
expressed as TNFα/β-actin and caspase-3/β-actin ratios.
Statistical Analyses
SPSS 19.0.0 software (IBM Software, NY, USA) was used for
statistical analyses. All data are expressed as mean ± standard
error of the mean (SEM). Comparisons between groups were
performed by Kruskall-Wallis one-factorial analysis of variance
by ranks with Dunn’s post-hoc test. A P < 0.05 was considered to
be statistically significant.
RESULTS
Normothermic and hypothermic sham operated groups of
animals without HI are included in the Supplementary Materials.
Piglets from all experimental groups were similar in terms of
age, weight and physiological parameters (Table 1), except for
mean arterial blood pressure and aEEG (Figure 1). The hypoxic-
ischemic insult induced a decrease in pH in all injured animals
(H interval, Table 1). After hypothermic therapy begins, pH
levels significantly recovered toward baseline levels at the drug
treatment (D interval, Table 1) in both HV and HC groups. At
the end of experiment (E interval, Table 1), mean pH level in
HC group was significantly higher than in the other groups. In
normothermia-treated animals, the hypoxic-ischemic insult led
to a decrease in mean arterial blood pressure that spontaneously
recovered in the following 30min.
In the NV group mean arterial blood pressure values dropped
again throughout the post-HI period (Figure 1A); in a half of the
animals (5 animals), dopamine infusion (at 10–20µg/kg/min)
was needed to maintain mean arterial blood pressure over 40
mmHg. Hypothermia was associated with a decrease in mean
arterial blood pressure in all groups (Figure 1A), although
dopamine infusion was not administered since the mean arterial
blood pressure did not fall under 40 mmHg in any of the piglets.
No such decline in the mean arterial blood pressure was observed
in the HI-injured piglets treated with normothermia and CBD,
and these animals did not require dopamine.
After injury, basal aEEG amplitude was decreased below 4
µV in all normothermic and hypothermic groups (Figure 1B).
The depressed activity remained unchanged in both NV, HV and
HC groups during all experiment, but was partially recovered at
the end of the experiment in NC group. Electrical seizures were
detected in one piglet from the HV group and one from the HC
group.
Effects of the Treatments on the
Characteristics of Excitotoxicity
The Glu/NAA ratio was higher in the NV group than in the
HV group (Figure 2). Cannabidiol treatment alone (NC group)
reduced Glu/NAA ratio to a similar extent compared to the levels
in HV group. The administration of both therapies (hypothermia
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TABLE 1 | General and physiological parameters.
Group NV NC HV HC
Sample size (n = 9) (n = 11) (n = 8) (n = 8)
Age (days) 1.8 (0.1) 1.9 (0.1) 1.6 (0.1) 1.7 (0.1)
Weight (kg) 1.7 (0.1) 1.9 (0.1) 1.6 (0.1) 1.6 (0.1)
CO
(ml/min/100 g)
B 339 (35) 357 (25) 315 (11) 301 (41)
H 355 (34) 321 (66) 410 (28) 402 (32)
D 369 (41) 334 (41) 317 (15) 262 (26)
E 344 (42) 336 (43) 324 (27) 292 (20)
pH B 7.32 (0.02) 7.35 (0.02) 7.36 (0.01) 7.41 (0.03)
H 7.17 (0.04) 7.20 (0.04) 7.23 (0.04) 7.24 (0.03)
D 7.21 (0.03) 7.20 (0.05) 7.36 (0.03)** 7.40 (0.03)**
E 7.32 (0.03) 7.32 (0.02) 7.34 (0.02) 7.42 (0.03)***
pCO2 (mm Hg) B 39.4 (1.9) 40.7 (2.6) 40.5 (1.5) 39.4 (2.6)
H 39.2 (2.9) 40.1 (3.3) 43.4 (1.5) 44.4 (2.9)
D 42.4 (2.2) 43.4 (2.3) 37.4 (3.2) 38.0 (3.0)
E 42.2 (2.9) 42.3 (1.6) 43.3 (1.8) 37.2 (2.2)
Mean values± SEM (given in brackets) obtained from 1- to 2-day-old piglets after hypoxic-
ischemic insult, treated with normothermia or hypothermia and administered with either
vehicle or cannabidiol. B, Baseline; H, end of HI, D, Drug; E, End of the experiment (**)
P < 0.05 vs. both normothermic groups (NV and NC) by Kruskall-Wallis one-factorial
analysis of variance; (***) P < 0.05 vs. all groups by Kruskall-Wallis one-factorial analysis
of variance.
and CBD) together produced additive effects, so the Glu/NAA
ratio in the HC group was lower to that observed in HV or NC
groups.
Effect of the Treatments on the
Characteristics of Oxidative Stress
A lower mean value of OxyBlot/Red Ponceau ratio in the
analyzed proteins from the parietal cortex was observed in the
HV group than in NV group (Figure 3), indicating a reduction
of protein carbonylation. A single dose of CBD after HI (NC
group) induced a similar effect on this ratio as in the HV group
(Figure 3). The mean levels of OxyBlot/Red Ponceau ratio were
lower in the HC group than in the HV or NC groups, suggesting
that administration of hypothermia together with CBD led to an
additive effect.
Effect of the Treatments on the
Characteristics of Neuroinflammation
Hypothermia treatment led to a reduction of TNFα content in
the parietal cortex of animals from the HV group as compared
to the NV group (Figure 4). With the administration of CBD in
normothermia, brain TNFα concentration was almost 18% lower
than in the NV group. Again, the combination of two treatments
resulted in an additive effect: TNFα levels in the HC group were
lower than those in the NC or HV groups.
Effects of the Treatments on the
Characteristics of Brain Damage
HI-induced brain damage and treatment-induced effects were
both observed in the histological and biochemical analyses.
FIGURE 1 | Mean arterial blood pressure and amplitude-integrated
electroencephalography (aEEG) in experimental groups of piglets. Line
draws represent the mean arterial blood pressure (A) and the mean aEEG (B),
obtained from 1- to 2-day-old piglets after hypoxic-ischemic insult, treated
with normothermia (shaded symbol) or hypothermia (empty symbol) and
administered with either vehicle (square) or cannabidiol (triangle). Data are
represented as mean ± SEM. (*) P < 0.05 vs. NV group by Kruskall-Wallis
one-factorial analysis of variance; (**) P < 0.05 vs. both normothermic groups
(NV and NC) by Kruskall-Wallis one-factorial analysis of variance; (***) P < 0.05
vs. all groups by Kruskall-Wallis one-factorial analysis of variance.
At the end of the experiment, about a quarter of neurons in
the cortex of the NV group animals appeared to be necrotic
(Figure 5A). Either hypothermia treatment (HV group) or CBD
administration (NC group) alone reduced this percentage to
a similar extent. Administration of both therapies together
produced an additive effect bringing the per cent of necrotic
neurons in the HC group down compared to the NC or HV
animals.
The expression of caspase-3 was reduced in the HV group in
comparison to NV group (Figure 5B). Moreover, the NC group
showed a significant reduction of caspase-3 levels in comparison
to the NV group. In this case the effect was so strong that caspase-
3 levels in HV group were similar to those inHC, with no additive
effect shown by combining hypothermia and CBD.
The Lac/NAA ratio was reduced in the HV group in
comparison to NV group (Figure 5C). Also, the effect of
hypothermia alone (HV group) was slightly greater than that
of CBD alone (NC group) after HI. Administering the two
treatments together resulted in an additive effect, the Lac/NAA
ratio in the HC group being lower than that in the NC and HV
groups.
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FIGURE 2 | Effect of the treatments on the characteristics of excitotoxicity. (A) A representative brain spectra from a hypoxic-ischemic animal managed with
normothermia (NV group). Arrows show the metabolite peaks of glutamate (Glu), N-acetylaspartate (NAA) and lactate (Lac). (B) Bars represent the results of Glu/NAA
ratio (mean ± SEM), in brain samples from 1- to 2-day-old piglets after hypoxic-ischemic insult, treated with normothermia or hypothermia and administered with
either vehicle or cannabidiol. (*) P < 0.05 vs. NV group by Kruskall-Wallis one-factorial analysis of variance; (***) P < 0.05 vs. all groups by Kruskall-Wallis one-factorial
analysis of variance.
DISCUSSION
Although not completely conclusive because of the short-term
follow-up, this study suggests that CBD and hypothermia could
complement each other in their protective mechanisms resulting
in a reduced brain injury in hypoxic-ischemic newborn piglets. In
fact, the combination of the two therapies leads to better results
in terms of anti-excitotoxicity, anti-inflammation and anti-
oxidation than those observed with either CBD or hypothermia
alone.
Excitotoxicity, inflammation and oxidative stress, the “deadly
triad” leading to HI-induced brain damage, are particularly
damaging for the immature brain (Johnston et al., 2011; Drury
et al., 2014; Juul and Ferriero, 2014). In particular, the high
concentration and activity of glutamate receptors aggravate
the deleterious effects of this excitatory amino acid in the
immature brain (Johnston et al., 2011; Drury et al., 2014; Juul
and Ferriero, 2014). Among various approaches to quantify the
increase in glutamate content in the immature brain after a
hypoxic-ischemic insult, the Glu/NAA ratio has been observed
to be closely related to excitotoxic brain damage (Groenendaal
et al., 2001). The relative paucity of antioxidants and excess
of pro-oxidant substances (in particular, iron) determine the
particular susceptibility of the immature brain to oxidative
stress (Johnston et al., 2011). HI-induced increases in oxidative
stress can be assessed by quantifying protein carbonylation,
an irreversible type of oxidative damage leading to functional
loss observed in brain cells after ischemia/reperfusion (Oikawa
et al., 2009) and detectable very shortly after HI in the piglet
brain (Mueller-Burke et al., 2008; Pazos et al., 2013). There is
increasing evidence supporting the importance of inflammation
in the pathophysiology of acute brain damage and its long-
lasting impact on the immature brain after HI insults (Allan and
Rothwell, 2001; Johnston et al., 2011; Drury et al., 2014; Juul and
Ferriero, 2014). In particular, the increase in TNFα production
after HI, which occurs as early as 1 h after insult, correlates with
the extent of injured tissue and with clinical outcomes (Allan and
Rothwell, 2001).
In this study, for the first time, we have presented evidence
of hypothermia acting simultaneously on these three factors in
HI-injured piglets. There are few studies directly demonstrating
the anti-excitotoxic effect of hypothermia in HI-injured piglets.
Using microdialysis studies, it was previously shown that
hypothermia reduces the glutamate increase seen after HI
(Thoresen et al., 1997). Here, we have reported that hypothermia
attenuates the HI-induced increase in the Glu/NAA ratio. As for
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FIGURE 3 | Effect of the treatments on the characteristics of oxidative
stress. (A) A representative image of immunoblotting indicating protein
carbonyl formation (Oxyblot) using anti-DNPH antibody. Samples were
obtained using brain tissue from 1- to 2-day-old piglets after hypoxic-ischemic
insult, treated with normothermia or hypothermia and administered with either
vehicle or cannabidiol. (B) Relative protein carbonyl levels were quantified by
densitometric analyses of the blots. The content of oxidized proteins was
normalized by total Red Ponceau-stained protein loading and expressed as
OxyBlot/Red Ponceau ratio (see Materials and Methods for details). Bars
represent mean ± SEM of 6–8 experiments. (a.u.) arbitrary units; (*) P < 0.05
vs. NV group by Kruskall-Wallis one-factorial analysis of variance; (***) P < 0.05
vs. all groups by Kruskall-Wallis one-factorial analysis of variance.
oxidative stress, it has been reported that hypothermia reduces
the HI-induced increase in protein carbonyl formation seen
in the piglet brain 6 h after HI (Mueller-Burke et al., 2008).
This effect was confirmed in our experiments. In the present
study we have found that hypothermia reduces TNFα production
in the HI-injured piglet brain. There are no previous reports
on the effects of hypothermia on TNFα production in the
brain of newborn pigs in vivo. Other authors have reported
that hypothermia reduces the LPS-induced increase in TNFα
production seen in cultured microglial cells (Schmitt et al.,
2007). It was found that gaseous hypothermia can modulate
inflammation and phagocytosis in aged rat brain after cerebral
ischemia (Joseph et al., 2012; Sandu et al., 2016). In addition, it is
known that hypothermia modulates the serum cytokine increase
observed in HI infants (Jenkins et al., 2012).
This work confirms that CBD is also a pleiotropic substance
that modulates excitotoxicity (blocking the increase in Glu/NAA
FIGURE 4 | Effect of the treatments on the characteristics of
neuroinflammation. (A) A representative image of immunoblotting using
anti-TNFα antibody, carried out on the samples from 1- to 2-day-old piglets
after hypoxic-ischemic insult, treated with normothermia or hypothermia and
administered with either vehicle or cannabidiol. (B) Densitometric analysis of
relative TNFα contents. β-actin was used to normalize for the differences in
protein loading between lanes in the blot. Bars represent mean ± SEM of 6-8
experiments. (a.u.) arbitrary units; (*) P < 0.05 vs. NV group by Kruskall-Wallis
one-factorial analysis of variance; (***) P < 0.05 vs. all groups by
Kruskall-Wallis one-factorial analysis of variance.
ratio), oxidative stress (preventing the increase in carbonylated
proteins) and inflammation (reducing the increase in TNFα
production) in HI-injured animals at short-term outcome. CBD
reduces both the in vitro and in vivo release of glutamate, as
previously demonstrated in slices of newborn mice forebrain
exposed to oxygen-glucose deprivation (Castillo et al., 2010), and
in the brain of HI rats (Pazos et al., 2012). This compound is
a potential antioxidant either due to its molecular properties
(Hampson et al., 1998) or because it can modulate the expression
of iNOS and free radicals after HI (Johnston et al., 2011; Juul
and Ferriero, 2014). In previous studies, we have shown that
the significant release of free radicals associated with iNOS after
HI, is especially harmful in newborn mice (Castillo et al., 2010).
Further, it reduces the release of cytokines (IL-1, IL-6, TNFα)
after an HI insult, as demonstrated in newborn rodents in vitro
(Castillo et al., 2010) and in vivo (Pazos et al., 2012).
Interestingly, the combination of hypothermia and CBD
produced an evident accumulative effect acting on the
same characteristics of excitotoxicity, oxidative stress and
inflammation compared to either CBD or hypothermia
alone. This finding suggests that the mechanism by which
CBD modulates those factors does not interfere with that
of hypothermia. On the contrary, it suggests that CBD and
hypothermia probably act complementarily on brain-damaging
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FIGURE 5 | Effect of the treatments on the characteristics of brain lesion. (A) Representative light microphotographs of Nissl-stained brain sections, obtained
from 1- to 2-day-old piglets after hypoxic-ischemic insult, treated with normothermia or hypothermia and administered with either vehicle or cannabidiol. The number
of pyknotic cells was significantly higher in the NV group (arrows), while it was lower in the hypothermia and cannabidiol-treated groups. Original magnification x200,
white bar: 100µm. (B) Top: A representative image of immunoblotting using an anti-Caspase-3 antibody, carried out on the samples from 1- to 2-day-old piglets after
hypoxic-ischemic insult, treated with normothermia, or hypothermia and administered with either vehicle or cannabidiol. Bottom: Densitometric analysis of relative
caspase-3 contents. β-actin was used to normalize for differences in protein loading between lanes of the blot. (C) Changes in Lac/NAA ratio obtained by H+-MRS
analysis of brain samples from 1- to 2-day-old piglets after hypoxic-ischemic insult, treated with normothermia or hypothermia and administered with either vehicle or
cannabidiol. Lac: lactate; NAA: N-acetylaspartate. In all figures, bars represent mean ± SEM of 6–10 experiments. (a.u.) arbitrary units. (*) P < 0.05 vs. NV group by
Kruskall-Wallis one-factorial analysis of variance; (**) P < 0.05 vs. both normothermic groups (NV and NC) by Kruskall-Wallis one-factorial analysis of variance; (***)
P < 0.05 vs. all groups by Kruskall-Wallis one-factorial analysis of variance.
pathways during the same phase or at different time intervals.
This indicates that CBD is potentially a good partner for
hypothermia treatment. In addition, CBD showed a very similar
profile to hypothermia regarding its effects on the parameters
characterizing brain damage after HI. This indicates that CBD
might be, in addition to an important adjunct to hypothermia, a
valuable alternative whenever the latter is not feasible.
Previously, we have reported that HI injury induced an
increase in the number of necrotic neurons in the cortex.
Both hypothermia (Mueller-Burke et al., 2008) and CBD alone
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(Alvarez et al., 2008; Pazos et al., 2013) reduced the neuronal
death in hypoxic-ischemic piglets, as early as 6 h after the
injury. Caspases, including caspase-3, are good markers of the
activation of apoptotic pathways (Drury et al., 2014). It has
been demonstrated that CBD reduces the eﬄux of caspase-9 as
observed in newborn mice forebrain slices exposed to oxygen
glucose deprivation (Castillo et al., 2010), and hypothermia
reduces caspase-3 expression in newborn rats and fetal sheep
(Drury et al., 2014). However, hypothermia alone did not
significantly reduce the number of TUNEL+ and caspase-3
immunoreactive cells in the cortex of piglets, 48 h after a hypoxic-
ischemic insult (Faulkner et al., 2011). Although no additive effect
on caspase-3 was observed, the disagreement between these and
our results may be due to the different follow-up periods and/or
the different methods used to induce HI brain damage.
Lactate accumulates in the brain after HI as a result of
mitochondrial dysfunction, whereas NAA content decreases
when the number of viable neurons and oligodendrocytes
decreases; thus, the Lac/NAA ratio is an excellent indicator
of hypoxic-ischemic brain injury (Vial et al., 2004; Munkeby
et al., 2008). In hypoxic-ischemic piglets, Lac/NAA ratio is
closely correlated with the results from TUNEL and microglial
ramification studies (Faulkner et al., 2011). In our study,
both CBD and hypothermia alone attenuated the HI-induced
modification in Lac/NAA in the cortex, in agreement with
previous reports (Faulkner et al., 2011; Pazos et al., 2013).
Moreover, the combination of hypothermia and CBD produced
the best protective effects, being the most effective treatment to
reduce histological brain damage and the Lac/NAA ratio. Well-
known neuroprotective agents, such as xenon (Chakkarapani
et al., 2010; Faulkner et al., 2011) or melatonin (Robertson et al.,
2013), have also been demonstrated to augment hypothermia
neuroprotection in the brain of injured piglets. We cannot rule
out the possibility that brain damage was somehow mitigated in
NV animals, since the use of dopamine infusion could reduce
brain damage in some experimental models of newborn pigs
(Park et al., 2003). However, neither CBD nor the combination
of the therapies were associated with acute hypotensive episodes
that would require inotropic support. In addition, a remarkable
recovery of aEEG amplitude was observed in HC but not in
HV animals. A similar effect has been previously described
for CBD in asphyxiated piglets (Alvarez et al., 2008; Pazos
et al., 2013) in association with the improvement of brain
metabolism and the reduction of brain edema and histological
damage. In this case a possible additive effect of CBD and
hypothermia could not be assessed since hypothermia led
to the flattening of aEEG trace throughout the experiment,
as previously reported in similar models (Robertson et al.,
2013).
Although providing encouraging results, the main limitation
of our work is the short duration of the follow-up after the
HI insult. In immature brain, the initial HI insult is usually
followed by a latent period lasting for 6–24 h. During this period
the aforementioned “deadly triad” (excitotoxicity, inflammation
and oxidative stress) initiates various pathological processes that
eventually lead to a secondary deterioration due to delayed
energy failure (Johnston et al., 2011; Drury et al., 2014; Juul
and Ferriero, 2014). Once initiated, most of these processes are
thought to be irreversible (Drury et al., 2014). Theoretically,
therefore, neuroprotective strategies must be applied prior to
the onset of such irreversible processes (Drury et al., 2014).
That is why the window for initiating neuroprotective strategies,
such as hypothermia, is up at the start of the latent period,
which usually is 6 h following HI insult. Hence, studying
whether a neuroprotective treatment can effectively modulate
excitotoxicity, inflammation and oxidative stress before the
latent phase is a necessary early step to establish whether
such treatment can be considered potentially useful (Mueller-
Burke et al., 2008). In this context, our data suggest that CBD
combined with hypothermia has beneficial modulatory effects
when applied at short term. However, since the aforementioned
processes are still working beyond the latent phase spreading
and aggravating the damage (Drury et al., 2014), neuroprotective
strategies are administered for at least 48 h in experimental
conditions (Chakkarapani et al., 2010; Faulkner et al., 2011;
Robertson et al., 2013) or, as for hypothermia (Johnston et al.,
2011; Drury et al., 2014; Juul and Ferriero, 2014), in the
clinical practice. It has been demonstrated, for instance, that
gaseous hypothermia has different therapeutic effects on aged
rats after cerebral ischemia depending whether the treatment
was administered for 24 or 48 h (Joseph et al., 2012; Sandu
et al., 2016). Another limitation of our study is the short
lapse between the end of the HI insult and the initiation of
the treatment. This short lapse is useful in terms of studying
the effects of the treatments on the different cellular processes
initiated by HI but is unrealistic in clinical terms. Therefore,
before considering this treatment for clinical use it would be
necessary to determine whether the neuroprotective effects of
cannabidiol combined with hypothermia still act throughout
the secondary deterioration period, which will require further
experiments extending the monitoring period beyond 48 h
after HI and with a more prolonged lapse between HI and
treatments. Finally, other interventions, like anesthesia, can
also significantly modulate the damaging processes and interact
in exactly the same way in all anesthetized animals acting
as potential neuroprotective agents. However, ethical aspects
preclude the elimination of the anesthesia/analgesia and their
effects cannot be specified.
In conclusion, CBD and hypothermia applied at short
term act on the same processes related to HI brain damage,
modulating excitotoxicity, inflammation, and oxidative stress.
These two therapies in combination do not compete which
each other in modulating these processes, but rather produce
additive effects, resulting in greater overall benefit. Whether
or not this combination produces effective long-term additive
neuroprotection should be tested using longer follow-up studies
and a “realistic” delay of treatment.
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